Anavex Life Sciences Ownership | Who Owns Anavex Life Sciences?
Anavex Life Sciences Ownership Summary
Anavex Life Sciences is owned by 32.96% institutional investors, 3.05% insiders, and 63.99% retail investors. Blackrock is the largest institutional shareholder, holding 7.75% of AVXL shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.99% of its assets in Anavex Life Sciences shares.
AVXL Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Anavex Life Sciences | 32.96% | 3.05% | 63.99% |
Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock | 6.39M | 7.75% | $26.97M |
Vanguard group | 4.55M | 5.52% | $19.19M |
State street | 3.74M | 4.54% | $15.78M |
Geode capital management | 1.83M | 2.22% | $7.73M |
Two sigma investments, lp | 1.01M | 1.23% | $4.27M |
Northern trust | 669.16K | 0.81% | $2.82M |
Charles schwab investment management | 651.08K | 0.79% | $2.75M |
Two sigma advisers, lp | 633.00K | 0.77% | $2.67M |
Renaissance | 466.44K | 0.57% | $1.97M |
Goldman sachs group | 457.16K | 0.55% | $1.93M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Allsquare wealth management | 51.97K | 0.13% | $219.30K |
Gsa capital partners llp | 220.86K | 0.07% | $932.00K |
Saxon interests | 26.70K | 0.05% | $112.67K |
Hikari power | 85.58K | 0.03% | $361.00K |
Sculptor capital lp | 370.40K | 0.03% | $1.56M |
Opus capital group | 32.70K | 0.02% | $138.00K |
Hayek kallen investment management | 11.86K | 0.02% | $50.00K |
Foster victor wealth advisors | 35.66K | 0.02% | $207.91K |
Geneos wealth management | 89.72K | 0.02% | $378.64K |
Hamilton point investment advisors | 20.30K | 0.02% | $85.67K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Two sigma advisers, lp | 633.00K | 0.01% | 584.50K |
Two sigma investments, lp | 1.01M | 0.01% | 477.34K |
Renaissance | 466.44K | 0.00% | 386.54K |
Gsa capital partners llp | 220.86K | 0.07% | 199.97K |
Jane street group | 181.95K | 0.00% | 137.05K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
State street | 3.74M | 0.00% | -3.56M |
Nwam | - | - | -836.73K |
Jupiter asset management | - | - | -804.64K |
Citigroup | 53.51K | 0.00% | -518.14K |
Rafferty asset management | 224.31K | 0.00% | -445.63K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Hrt financial lp | 94.20K | 0.00% | 94.20K | $397.00K |
Mirae asset global etfs | 45.87K | 0.00% | 45.87K | $194.15K |
Corebridge financial | 39.16K | 0.00% | 39.16K | $165.27K |
Activest wealth management | 4.00K | 0.01% | 4.00K | $16.88K |
Allspring global investments | 2.15K | - | 2.15K | $9.08K |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -14.00 |
Russell investments group | -115.00 |
Bangor savings bank | -150.00 |
Coston, mcisaac & partners | -200.00 |
Cypress capital | -700.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 151 | 1.34% | 27,864,882 | 4.09% | 32 | 3.13% | 72 | 16.13% | 30 | -33.33% |
Jun 30, 2024 | 148 | -6.33% | 26,770,748 | -15.94% | 32 | 2.16% | 62 | -17.33% | 44 | - |
Mar 31, 2024 | 158 | -5.39% | 31,845,742 | 23.59% | 38 | 3.94% | 75 | -11.76% | 44 | 15.79% |
Dec 31, 2023 | 167 | 9.87% | 25,766,532 | 3.24% | 31 | 3.30% | 85 | 19.72% | 38 | -15.56% |
Sep 30, 2023 | 152 | -0.65% | 24,959,010 | -0.86% | 30 | 2.99% | 71 | 10.94% | 45 | -6.25% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 2.53M | 2.99% | - |
iShares Russell 2000 ETF | 1.95M | 2.30% | -4.38K |
SPDR® S&P Biotech ETF | 1.54M | 1.82% | 17.03K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.33M | 1.56% | -5.09K |
Fidelity Small Cap Index | 746.32K | 0.88% | -16.92K |
iShares Biotechnology ETF | 581.95K | 0.69% | -3.48K |
iShares Russell 2000 Value ETF | 523.42K | 0.62% | - |
Fidelity Extended Market Index | 493.58K | 0.58% | -16.67K |
State St Russell Sm/Mid Cp® Indx NL Cl C | 441.70K | 0.52% | -16.40K |
Schwab US Small-Cap ETF™ | 407.25K | 0.48% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jun 14, 2024 | Donhauser Peter D.O. | - | Buy | $10.32K |
May 15, 2024 | Thomas Steffen | - | Buy | $22.60K |
Mar 28, 2024 | MISSLING CHRISTOPHER U | President and CEO | Sell | $374.97K |
Jun 28, 2023 | MISSLING CHRISTOPHER U | President and CEO | Sell | $2.14M |
May 25, 2022 | Skarpelos Athanasios | Sell | $453.00K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q2 | 1 | - |
2024 Q1 | - | 1 |
2023 Q2 | - | 1 |
2023 Q1 | - | - |
2022 Q2 | - | 1 |
AVXL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools